BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30596268)

  • 1. Clinical Significance of Prognostic Nutritional Index for Patients with Diffuse Large B-cell Lymphoma.
    Yu W; Guo Q; Wang Z; Mao L; Wei J; Jin J; Wang J
    Nutr Cancer; 2019; 71(4):569-574. PubMed ID: 30596268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geriatric nutritional risk index is not an independent predictor in patients with diffuse large B-cell lymphoma.
    Li Z; Guo Q; Wei J; Jin J; Wang J
    Cancer Biomark; 2018; 21(4):813-820. PubMed ID: 29504524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of prognostic nutritional index in diffuse large B cell lymphoma.
    Go SI; Park S; Kang MH; Kim HG; Kim HR; Lee GW
    Ann Hematol; 2019 Feb; 98(2):401-411. PubMed ID: 30413902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP.
    Zhou Q; Wei Y; Huang F; Wei X; Wei Q; Hao X; Zhang Y; Feng R
    Int J Hematol; 2016 Oct; 104(4):485-90. PubMed ID: 27393279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic nutritional index as a predictor of prognosis in patients with diffuse large B cell lymphoma.
    Periša V; Zibar L; Knezović A; Periša I; Sinčić-Petričević J; Aurer I
    Wien Klin Wochenschr; 2017 Jun; 129(11-12):411-419. PubMed ID: 27637206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of the prognostic nutritional index (PNI) in patients with newly diagnosed, CD5-positive diffuse large B-cell lymphoma: A multicenter retrospective study of the Huaihai Lymphoma Working Group.
    Ma S; Zhang B; Lu T; Li D; Li T; Shen Z; He C; Wang Y; Li B; Zhang H; Gu W; Wang C; Ye J; Zhu T; Miao Y; Wang L; Huang S; Liu Q; Sang W;
    Cancer; 2022 Oct; 128(19):3487-3494. PubMed ID: 35932292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma.
    Matsukawa T; Suto K; Kanaya M; Izumiyama K; Minauchi K; Yoshida S; Oda H; Miyagishima T; Mori A; Ota S; Hashimoto D; Teshima T;
    Ann Hematol; 2020 Dec; 99(12):2859-2868. PubMed ID: 32970194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison and exploration of the prognostic value of the advanced lung cancer inflammation index, prognostic nutritional index, and systemic immune-inflammation index in newly diagnosed diffuse large B-cell lymphoma.
    Liu T; Ye F; Li Y; Liu A
    Ann Palliat Med; 2021 Sep; 10(9):9650-9659. PubMed ID: 34628890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
    Oki Y; Yamamoto K; Kato H; Kuwatsuka Y; Taji H; Kagami Y; Morishima Y
    Eur J Haematol; 2008 Dec; 81(6):448-53. PubMed ID: 18691256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel prognostic index based on hemoglobin level and platelet count for diffuse large B-cell lymphoma, not otherwise specified in the R-CHOP era.
    Nakayama S; Matsuda M; Adachi T; Sueda S; Ohashi Y; Awaji S; Hashimoto S; Matsumura I
    Platelets; 2019; 30(5):637-645. PubMed ID: 30047815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
    Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
    [No Abstract]   [Full Text] [Related]  

  • 12. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
    Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ
    Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of inflammatory parameters and nutritional index in clinical stage IVB endometrial carcinomas.
    Kiuchi K; Hasegawa K; Ochiai S; Motegi E; Kuno T; Kosaka N; Fukasawa I
    J Obstet Gynaecol; 2019 Feb; 39(2):237-241. PubMed ID: 30370797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma.
    Lu TX; Wu S; Cai DY; Hong TT; Zhang Y; Gao HQ; Hua HY; Wu XH
    BMC Cancer; 2019 Jun; 19(1):553. PubMed ID: 31176361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
    Nakatani M; Migita K; Matsumoto S; Wakatsuki K; Ito M; Nakade H; Kunishige T; Kitano M; Kanehiro H
    Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Useful prognostic tools based on complete blood cell counts in diffuse large B-cell lymphoma.
    Shimono J; Takahashi S; Takemura R; Kakinoki Y
    Int J Lab Hematol; 2019 Dec; 41(6):754-761. PubMed ID: 31529774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
    Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
    J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
    Yao N; Hou Q; Zhang S; Xiao H; Liang Y; Xu X; Guo R; Li H; Lan S; Si H; Cao J
    Front Oncol; 2020; 10():877. PubMed ID: 32637354
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

  • 20. High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma.
    Chang C; Wu SY; Kang YW; Lin KP; Chen TY; Medeiros LJ; Chang KC
    Am J Clin Pathol; 2015 Dec; 144(6):935-44. PubMed ID: 26573001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.